The Leqembi dosage your doctor prescribes will depend on your body weight and the results of your MRI scans. Specifically, your doctor will monitor your scans for amyloid-related imaging ...

Leqembi has a better safety profile, but patients taking it must receive regular MRI scans to monitor for a potential side effect of imaging abnormalities that can manifest as brain swelling or ...

People who take Leqembi and Kisunla are required to get an MRI brain scan once a quarter ... scan or to visit a healthcare provider. “The monitoring would need to be done either way, but if ...

The European Union’s medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen’s Alzheimer’s ...

However, in July 2023, new dementia drug Leqembi (lecanemab) received full approval from the Food and Drug Administration (FDA) on the basis of an 18-month, double-blind, phase 3 clinical trial ...

While Leqembi sales performed well outside the ... help reduce challenges related to MRI scans. Given the guidance of a year-over-year revenue decline, the HC Wainwright analyst re-evaluates ...

LEQEMBI is indicated for the treatment of ... Monitoring and Dose Management Guidelines Baseline brain MRI and periodic monitoring with MRI are recommended. Enhanced clinical vigilance for ARIA ...

LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...

Leqembi can cause brain swelling or bleeding, and patients must also undergo an MRI before treatment and several during treatment to monitor this risk, according to the U.S. Food and Drug ...